SQZ Biotechnologies Company (SQZB)
USD 0.03
(1.82%)
USD 0.03
(1.82%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 27.47 Million USD | -60.58% |
| 2021 | 69.69 Million USD | 47.98% |
| 2020 | 47.09 Million USD | 11.25% |
| 2019 | 42.33 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 22.35 Million USD | -8.74% |
| 2023 Q1 | 24.49 Million USD | -10.82% |
| 2023 Q3 | 21.47 Million USD | -3.97% |
| 2022 Q1 | 67.31 Million USD | -3.4% |
| 2022 Q3 | 62.45 Million USD | -3.82% |
| 2022 Q4 | 27.47 Million USD | -56.01% |
| 2022 Q2 | 64.93 Million USD | -3.55% |
| 2022 FY | 27.47 Million USD | -60.58% |
| 2021 Q3 | 71.55 Million USD | 0.0% |
| 2021 FY | 69.69 Million USD | 47.98% |
| 2021 Q4 | 69.69 Million USD | -2.61% |
| 2020 FY | 47.09 Million USD | 11.25% |
| 2019 FY | 42.33 Million USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 33.328% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -566.455% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 36.663% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 7.714% |
| Mesoblast Limited | 118.7 Million USD | 76.857% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -2796.957% |
| Genus plc | 233.1 Million USD | 88.215% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -837.453% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -1944.606% |
| Marizyme, Inc. | 18.71 Million USD | -46.766% |
| ContraFect Corporation | 2.88 Million USD | -853.523% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -3562.8% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -20175.746% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -1799.374% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -1081.063% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -385.495% |
| MultiCell Technologies, Inc. | 202.58 USD | -13560468.664% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 52.215% |
| EV Biologics, Inc. | 1.49 Million USD | -1737.831% |
| Q BioMed Inc. | 4.1 Million USD | -568.397% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 17.009% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -4259.943% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -2136.395% |
| Biomind Labs Inc. | 735.54 Thousand USD | -3634.797% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 83.986% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -111.364% |
| Skye Bioscience, Inc. | 4.61 Million USD | -495.22% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -2993.358% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -19311.665% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -367.903% |
| IMV Inc. | 28.88 Million USD | 4.892% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -106712.084% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -1116.402% |
| GB Sciences, Inc. | 1.75 Million USD | -1461.467% |
| Alpha Cognition Inc. | 1.22 Million USD | -2151.035% |
| HST Global, Inc. | 98.31 Thousand USD | -27840.683% |
| CSL Limited | 12.18 Billion USD | 99.775% |
| Halberd Corporation | 150 Thousand USD | -18214.0% |
| Enzolytics Inc. | 996.33 Thousand USD | -2657.197% |
| Resverlogix Corp. | 6.49 Million USD | -323.217% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -5653.089% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -10647.989% |
| argenx SE | 20 Million USD | -37.355% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 39.704% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -914.175% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -268565.037% |
| Genscript Biotech Corporation | 417.73 Million USD | 93.424% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -13593.325% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -1045.712% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -11880.845% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 59.388% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -807.775% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -7536.985% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -35.139% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -18379.826% |
| BioStem Technologies, Inc. | 4.71 Million USD | -483.073% |
| ONE Bio Corp. | 19.71 Million USD | -39.34% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -10880.406% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -10944.95% |
| Agentix Corp. | 50 Thousand USD | -54842.0% |
| LadRx Corporation | 33.6 Thousand USD | -81644.331% |
| Cell Source, Inc. | 9.25 Million USD | -196.85% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -3532.75% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -3532.75% |
| NovAccess Global Inc. | 2.19 Million USD | -1148.75% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -288.403% |
| Itoco Inc. | 228.37 Thousand USD | -11928.794% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -12920.974% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -451.294% |
| Kadimastem Ltd | 891.22 Thousand USD | -2982.383% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -6736.15% |
| CytoDyn Inc. | 30.07 Million USD | 8.661% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -5572.498% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -7707.655% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -251.293% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -22325.306% |
| Rebus Holdings, Inc. | 310 Thousand USD | -8761.613% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -480.134% |
| International Stem Cell Corporation | 4.17 Million USD | -557.516% |
| Bioxytran, Inc. | 1.92 Million USD | -1327.065% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -43914.869% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -1159.618% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -230.339% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -219.988% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -1666.08% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -10150.373% |
| Neutra Corp. | 54.15 Thousand USD | -50625.681% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -1401.148% |
| PureTech Health plc | 25.51 Million USD | -7.679% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -2143.948% |
| IXICO plc | 472.02 Thousand USD | -5719.844% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -77.221% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 55.879% |
| CSL Limited | 12.18 Billion USD | 99.775% |
| Cellectis S.A. | 92.77 Million USD | 70.39% |